Buy One Get One free -Llimited Time Offer X
Brilinta 90 mg Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Heart Attack. The alternative uses of Brilinta 90 mg Tablet have also been explained below.
The optimal dosage of Brilinta 90 mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Brilinta 90 mg Tablet have been listed ahead. Such side effects of Brilinta 90 mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Brilinta 90 mg Tablet has a Moderate effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Brilinta 90 mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Brilinta 90 mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Brilinta 90 mg Tablet in conditions like Liver Disease, Bradycardia (Slow Heart Rate), Peptic Ulcer. Some other conditions that can be affected by Brilinta 90 mg Tablet are listed in the contraindications section below.
Drug reaction of Brilinta 90 mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Brilinta 90 mg Tablet is considered safe while driving, and is addictive.
Brilinta 90 mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Brilinta 90 mg Tablet safe for pregnant women?
Brilinta can have harmful effects in pregnant women. If you experience any discomfort after using Brilinta, then discontinue the use and take your doctor's advice.
Is the use of Brilinta 90 mg Tablet safe during breastfeeding?
In the absence of any scientific study about the side effects of Brilinta in breastfeeding women, information on safety of Brilinta is unavailable.
What is the effect of Brilinta 90 mg Tablet on the Kidneys?
Using Brilinta does not have any harmful effects on kidneys.
What is the effect of Brilinta 90 mg Tablet on the Liver?
Brilinta may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Brilinta 90 mg Tablet on the Heart?
Very few cases of side effects of Brilinta on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Brilinta 90 mg Tablet unless your doctor advises you to do so -
Is this Brilinta 90 mg Tablet habit forming or addictive?
Forming a habit of Brilinta 90 mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Brilinta 90 mg Tablet as it does not make you drowsy.
Is it safe?
Brilinta 90 mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Brilinta 90 mg Tablet in mental disorders is not effective.
Interaction between Food and Brilinta 90 mg Tablet
Due to the absence of research, it is difficult to say how Brilinta 90 mg Tablet and food will interact.
Interaction between Alcohol and Brilinta 90 mg Tablet
It is difficult to say anything about the effect of Brilinta 90 mg Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Brilinta® (ticagrelor)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1204-1205